PR
PRKWF.US Parkway Life Real Estate Investment Trust
- Market cap
- USD 1.93B
- P/E
- 14.8x
- P/B
- 1.48x
- ROE
- 6.3%
- Dividend yield
- 4.37%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is PRKWF.US undervalued?
Graham numberPRKWF.US trades 1.3% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Parkway Life Real Estate Investment Trust fundamental analysis
No fundamental analysis for Parkway Life Real Estate Investment Trust yet.
Parkway Life Real Estate Investment Trust stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Parkway Life Real Estate Investment Trust
Parkway Life Real Estate Investment Trust (PLife REIT) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine…
Full company profileParkway Life Real Estate Investment Trust financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Parkway Life Real Estate Investment Trust annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 110M | 110M | 113M | 115M | 121M | 121M | 130M | 147M | 145M | 165M | 154M |
| Gross Profit | 102M | 103M | 105M | 108M | 113M | 111M | 122M | 125M | 119M | 135M | 129M |
| Operating Income | 111M | 115M | 169M | 135M | 103M | 336M | 49.2M | 121M | 118M | 131M | 114M |
| EBITDA | 111M | 115M | 169M | 135M | 103M | 336M | 49.2M | 122M | 114M | 131M | - |
| Net Income | 91.9M | 101M | 152M | 123M | 87.2M | 332M | 41.1M | 100M | 95.0M | 153M | 106M |
| EPS | 0.15 | 0.17 | 0.25 | 0.20 | 0.14 | 0.55 | 0.07 | 0.17 | 0.16 | 0.30 | 0.16 |
| Balance Sheet | |||||||||||
| Total Assets | 1.74B | 1.77B | 1.89B | 2.00B | 2.07B | 2.35B | 2.34B | 2.33B | 2.55B | 2.65B | 2.66B |
| Total Liabilities | 702M | 706M | 758M | 821M | 883M | 910M | 932M | 920M | 981M | 982M | 979M |
| Shareholders' Equity | 1.04B | 1.07B | 1.14B | 1.18B | 1.18B | 1.43B | 1.41B | 1.41B | 1.57B | 1.67B | 1.68B |
| Cash & Short-term Investments | 71.1M | 25.7M | 22.1M | 21.9M | 22.7M | 25.8M | 40.0M | 28.5M | 29.5M | 47.7M | 58.5M |
| Total Debt | 629M | 642M | 683M | 742M | 794M | 828M | 852M | 828M | 886M | 887M | 903M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 87.5M | 80.7M | 88.4M | 89.2M | 90.3M | 89.9M | 94.6M | 109M | 95.8M | 99.4M | - |
| Capital Expenditure | 6.06M | 5.26M | 6.63M | 9.63M | 4.58M | 11.7M | 63.9M | 31.0M | 49.1M | 99.4M | 0.00 |
| Free Cash Flow | 81.5M | 75.5M | 81.7M | 79.6M | 85.7M | 78.2M | 30.7M | 77.7M | 46.7M | 36.1M | - |
| Ratios | |||||||||||
| ROE | 8.9% | 9.5% | 13.4% | 10.4% | 7.4% | 23.1% | 2.9% | 7.1% | 6.1% | 9.1% | 6.3% |
| ROA | 5.3% | 5.7% | 8.0% | 6.2% | 4.2% | 14.2% | 1.8% | 4.3% | 3.7% | 5.8% | 4.0% |
| Net Profit Margin | 83.5% | 92.3% | 134.6% | 107.1% | 72.2% | 274.9% | 31.6% | 68.1% | 65.4% | 92.6% | 68.7% |
| Debt to Equity | 0.61x | 0.60x | 0.60x | 0.63x | 0.67x | 0.58x | 0.60x | 0.59x | 0.56x | 0.53x | 0.54x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Parkway Life Real Estate Investment Trust dividends
- Dividend yield
- 4.37%
- Forward dividend
- 0.13 USD
- Payout ratio
- 42.8%
- Ex-dividend date
- Aug 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SGD 65.4M | 0.13 | 42.8% |
| 2024 | SGD 121M | 0.20 | 127.4% |
| 2023 | USD 88.4M | 0.15 | 88.0% |
| 2022 | SGD 64.3M | 0.11 | 156.3% |
| 2021 | USD 85.2M | 0.14 | 25.7% |
| 2020 | USD 82.0M | 0.14 | 94.1% |
| 2019 | USD 79.4M | 0.13 | 64.4% |
| 2018 | USD 78.5M | 0.13 | 51.6% |
| 2017 | USD 78.8M | 0.13 | 77.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Parkway Life Real Estate Investment Trust
- Insiders 33.21%
- Institutions 15.74%
- Public & others 51.05%
- Shares outstanding 653M
- Free float 438M
Parkway Life Real Estate Investment Trust company profile
- Company name
- Parkway Life Real Estate Investment Trust
- Ticker
- PRKWF.US
- Exchange
- USA Stocks
- Sector
- Real Estate
- Industry
- Diversified REITs
- Fiscal year end
- December
- Address
- 9 Raffles Place, Singapore, Singapore, 048619
- Phone
- 65 6236 3333
- Website
- plifereit.com
About Parkway Life Real Estate Investment Trust
Parkway Life Real Estate Investment Trust (PLife REIT) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 73 properties, with a total portfolio size of approximately S2.56 billion dollars as at 30 June 2026. It owns the largest portfolio of strategically located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 59 assets of high-quality nursing home and care facility properties in various prefectures of Japan, and 11 assets of high-quality nursing homes well located across six regions in France. Parkway Life Real Estate Investment Trust was established in 2007 and is incorporated in Singapore.
Parkway Life Real Estate Investment Trust management
10- Mr. Yean Chau YongCEO & Executive Director of Parkway Trust Management Limited · born 1966
- Mr. Hock Leong LooCFO & COO · born 1970
- Mr. Seak Sze TanChief Investment Officer of Parkway Trust Management Limited · born 1968
- Ms. Annie ChenVP & Head of Corporate Finance of Parkway Trust Management Limited
- Ms. Nicole ChuaAssistant VP & Head of Legal, Compliance & Strategic Human Resource Management
- Ms. Chin Ping TeoVP & Head of Projects of Parkway Trust Management Limited
- Mr. Shawn YapVP & Head of Special Projects
- Ms. Patricia NgVP & Head of Finance of Parkway Trust Management Limited
- Mr. Weng Bunn LeeVP & Head of Investment
- Ms. Zhi Lei TanSenior Manager & Head of Financial Accounting